The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

CARPHENAZINE THERAPY OF ACUTELY PSYCHOTIC PATIENTS IN THE PSYCHIATRIC WARD OF A GENERAL HOSPITAL

Published Online:https://doi.org/10.1176/ajp.121.12.1203

Twenty-eight patients who were acutely psychotic at the time of admission to the psychiatric ward of a general hospital were treated with carphenazine. Twenty-one patients (75%) were returned to the community as having recovered, after a median hospital stay of 25 days. This preliminary report indicates that carphenazine has a similar improvement rate to that of the more commonly used phenothiazines. Thus, it appears to have a wider range of activity than previously reported.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.